PAVmed Inc. Royalty Expense
PAVmed Inc. (PAVM) reported Royalty Expense of $23.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RoyaltyExpense · last filed 2023-03-14
- PAVmed Inc. royalty expense for the quarter ending 2021-12-31 was -$25.00K.
- PAVmed Inc. royalty expense for fiscal 2022 was $23.00K, a 8.00% decline from fiscal 2021.
- PAVmed Inc. royalty expense for fiscal 2021 was $25.00K.
| Period end | Royalty Expense 3 month | Royalty Expense 9 month | Royalty Expense 12 month |
|---|---|---|---|
| 2022-12-31 | $23.00K 10-K · filed 2023-03-14 | ||
| 2021-12-31 | -$25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $25.00K 10-K · filed 2023-03-14 | |
| 2021-09-30 | $50.00K 10-Q · filed 2021-11-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InspireMD, Inc. (NSPR) | $0.033B | ||
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |